Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Helicore Biopharma has raised $65.0M in total funding. The most recent round was Series A. The last funding was announced in January 2025.
Helicore Biopharma's investors include Wellington Management, OrbiMed, Versant Ventures, Longitude Capital.
Helicore Biopharma is headquartered in San Mateo, United States.
Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.
Helicore Biopharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Helicore Biopharma — Funding & Investors." VCBacked, January 28, 2025, https://www.vcbacked.co/company/helicore-biopharma. Accessed July 25, 2026.
VCBacked. (2025). Helicore Biopharma — Funding & Investors. Retrieved July 25, 2026, from https://www.vcbacked.co/company/helicore-biopharma
{{cite web |title=Helicore Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/helicore-biopharma |website=VCBacked |access-date=July 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated